Egenesis
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Series A
LATEST DEAL TYPE
$38M
LATEST DEAL AMOUNT
10
INVESTORS
Description
Developer of xenotransplantation for the benefit of human health. The company's technology helps in the transformation of xenotransplantation into a medical procedure.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 300 Technology Square
- Suite 301
- Cambridge, MA 02139
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Egenesis’s full profile, request a free trial.
Egenesis Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 16-Mar-2017 | $38M | 0000 | 000.00 | Completed | Startup |
Egenesis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Egenesis Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Synthego | Venture Capital-Backed | Redwood City, CA | 00 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Berkeley, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 000000000 | Venture Capital-Backed | Boulder, CO | 00000 | 00000000000 | 00000 | |
| 00000000 000000000 | Corporation | Cleveland, OH | 0 | 0000000000 | ||
| 000000000 00000000 | Venture Capital-Backed | San Diego, CA | 0 | 000.00 | 00000000000 | 000.00 |
Egenesis Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Alexandria Venture Investments | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Alta Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Berggruen Holdings | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Biomatics Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Egenesis Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Luhan Yang Ph.D | Co-Founder, President, Board Member & Chief Scientific Officer | ||
| George Church Ph.D | Co-Founder & Board Member |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »Egenesis Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Boris Nikolic MD | Biomatics Capital | Board Member | 000 0000 | |
| Daniel Lynch | Self | Chairman | 000 0000 | |
| George Church Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| Steven Gillis Ph.D | ARCH Venture Partners | Board Member | 000 0000 |